↓ Skip to main content

Uridine prevents tamoxifen-induced liver lipid droplet accumulation

Overview of attention for article published in BMC Pharmacology and Toxicology, May 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Uridine prevents tamoxifen-induced liver lipid droplet accumulation
Published in
BMC Pharmacology and Toxicology, May 2014
DOI 10.1186/2050-6511-15-27
Pubmed ID
Authors

Thuc T Le, Yasuyo Urasaki, Giuseppe Pizzorno

Abstract

Tamoxifen, an agonist of estrogen receptor, is widely prescribed for the prevention and long-term treatment of breast cancer. A side effect of tamoxifen is fatty liver, which increases the risk for non-alcoholic fatty liver disease. Prevention of tamoxifen-induced fatty liver has the potential to improve the safety of long-term tamoxifen usage.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 31%
Researcher 7 24%
Student > Doctoral Student 2 7%
Student > Bachelor 1 3%
Student > Master 1 3%
Other 3 10%
Unknown 6 21%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 14%
Psychology 3 10%
Agricultural and Biological Sciences 3 10%
Chemistry 3 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Other 7 24%
Unknown 7 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2022.
All research outputs
#15,309,575
of 23,543,207 outputs
Outputs from BMC Pharmacology and Toxicology
#228
of 454 outputs
Outputs of similar age
#128,764
of 227,968 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#4
of 9 outputs
Altmetric has tracked 23,543,207 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 454 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,968 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.